Similar articles

• Pulmonary disease from biological agents: anthrax, plague, Q fever, and tularemia.

  Daya M, Nakamura Y. Daya M, et al. Crit Care Clin. 2005 Oct;21(4):747-63, vii. doi: 10.1016/j.ccc.2005.06.009. Crit Care Clin. 2005. PMID: 16168313 Review.
• [Modern possibilities of bioterrorism diagnosis].

  Grzesiowski P, Szafraniec S, Chmylak B, Tylewska-Wierzbanowska S, Hryniewicz W. Grzesiowski P, et al. Pol Merkur Lekarski. 2003 Feb;14(80):142-5. Pol Merkur Lekarski. 2003. PMID: 12728676 Polish.
• Management of patients exposed to biologic weapons.

  Yetman RJ, Parks D, Taft E. Yetman RJ, et al. J Pediatr Health Care. 2002 Sep-Oct;16(5):256-61. J Pediatr Health Care. 2002. PMID: 12226595 Review. No abstract available.
• Ability of physicians to diagnose and manage illness due to category A bioterrorism agents.

  Cosgrove SE, Perl TM, Song X, Sisson SD. Cosgrove SE, et al. Arch Intern Med. 2005 Sep 26;165(17):2002-6. doi: 10.1001/archinte.165.17.2002. Arch Intern Med. 2005. PMID: 16186470
• Histopathology and immunohistochemistry in the diagnosis of bioterrorism agents.

  Guarner J, Zaki SR. Guarner J, et al. J Histochem Cytochem. 2006 Jan;54(1):3-11. doi: 10.1369/jhc.5R6756.2005. Epub 2005 Sep 7. J Histochem Cytochem. 2006. PMID: 16148309 Review.